Article Details
Retrieved on: 2024-05-16 16:37:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Executive Summary. CT-388 hits in Phase I, but there is a long way to go before the Carmot acquisition pays off. Roche. Existing Subscriber?
Article found on: scrip.citeline.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here